Closing Racial and Geographic Gaps in Blood Cancer Care
Closing Racial and Geographic Gaps in Blood Cancer Care Targeted Oncology
Closing Racial and Geographic Gaps in Blood Cancer Care Targeted Oncology
Researchers have uncovered a previously unknown gene that causes resistance to a leading blood cancer drug, as well as several genes that accelerate lymphoma growth, using a powerful new CRISPR activation library.
Dissolvable, microscopic needles light the way for cancer treatments EurekAlert!
Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, adaptive immune cells, in triggering and sustaining colitis as a side effect of immune checkpoint inhibitors, a widely used form of cancer immunotherapy.
Record gift will enable cutting research leading to cancer therapies for pets and humans WFIR News
A cancer cell behaves differently from a healthy cell, with unique features that enable rapid growth and bypass quality controls. Rice University's Natasha Kirienko is interested in finding these unique features and exploiting them to advance cancer treatments. In a paper recently published in the journal Leukemia…
Conversation with Community Giants: ‘From Diagnosis to Hope: The New Face of Cancer Care on Staten Island’ SILive.com
Экспериментальная терапия помогла 3-летнему мальчику полностью победить рак печени на поздней стадии Shazoo
Earlier Diagnosis and Better Care at the Heart of Cancer Improvement – CRUK Oncodaily
Researchers uncover how aggressive breast cancer may spread to the brain | Newswise Newswise
Adopting Reflex Biomarker Testing to Improve Clinical Workflows for Patients With Non–Small Cell Lung Cancer HMP Global Learning Network
Mayo Clinic researchers have identified a strategy that could help chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, overcome a major barrier to treating solid tumors: Cancer cells can change in ways that allow them to hide from immune cells designed to attack them.
BIOCYTICS AND EREMID GENOMIC SERVICES COLLABORATE ON RESEARCH STUDY FOR NOVEL SINGLE-CELL TRANSCRIPTOMICS IMMUNE-BASED CANCER CELL THERAPY PR Newswire
Wells Messersmith, MD, Named Director of CU Anschutz Cancer Center University of Colorado Anschutz